Online citations, reference lists, and bibliographies.
← Back to Search

Acromegaly And Aging: A Comparative Cross-sectional Study.

E. Hatipoğlu, M. Yuruyen, Ela Keskin, H. Yavuzer, M. Niyazoğlu, A. Doventas, D. Erdinçler, T. Beğer, P. Kadioglu, S. Gundogdu
Published 2015 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
OBJECTIVE Cognitive and functional geriatric assessment may change in acromegaly. Herein we aimed to determine at which points geriatric assessment of the cases with acromegaly differs from that of general elderly population. DESIGN In this comparative cross-sectional study, a total of 30 cases with acromegaly (controlled n = 14, uncontrolled n = 16) and 30 gender and body-mass index-matched cases without acromegaly (control group, CG) above 60 years old were included. Cognitive functions were evaluated on the basis of the mini-mental state exam (MMSE). Affective status was determined using the geriatric depression scale. Activities of daily living (ADL) were ranked according to the Barthel index while instrumental activities of daily living (IADL) were graded on the basis of the Lawton scale. Nutritional status was evaluated using the mini-nutritional assessment (MNA). Body composition was measured through bioimpedance analysis. Functional mobility was determined using the Timed Up and Go test (TUG) and muscle strength with the handgrip strength test. RESULTS Scores on the MMSE were significantly lower in the elderly cases with acromegaly than in the cases without acromegaly (p < 0.001). Dementia was more frequent in the acromegaly group than in the CG (p = 0.04). Total MNA scores were significantly lower in cases with acromegaly than in the CG (p = 0.006). More subjects in the acromegaly group (33%) were at greater risk of malnutrition than in the CG (3%) (p = 0.003). There was greater moderate functional impairment based on Barthel ADL in the acromegaly group than in the CG (p = 0.04). CONCLUSION Acromegaly may impair cognitive functions, functional mobility and instrumental daily living activities in the geriatric population. With acromegaly, the risk of malnutrition may also increase.
This paper references
10.1111/j.1365-2036.2010.04479.x
Deficiencies in fat‐soluble vitamins in long‐term users of somatostatin analogue
H. Fiebrich (2010)
10.1007/BF03345496
Gender- and age-related differences in the endocrine parameters of acromegaly
A. Colao (2002)
10.1111/j.1365-2265.2006.02584.x
Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly
A. Colao (2006)
10.1007/BF03345243
Effects of GH replacement on metabolism and physical performance in GH deficient adults
S. K. Abdul Shakoor (2003)
A simple index of insulin resistance.
J. Bastard (1997)
10.1152/AJPENDO.2001.281.6.E1159
Comparison of GH, IGF-I, and testosterone with mRNA of receptors and myostatin in skeletal muscle in older men.
T. Marcell (2001)
10.1111/j.1532-5415.2008.01854.x
Prevalence of Sarcopenia Estimated Using a Bioelectrical Impedance Analysis Prediction Equation in Community‐Dwelling Elderly People in Taiwan
M. Chien (2008)
10.1159/000093337
Effects of Growth Hormone Substitution Therapy on Cognitive Functioning in Growth Hormone Deficient Patients: A Functional MRI Study
L. Arwert (2006)
10.1001/JAMA.288.18.2282
Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.
M. Blackman (2002)
10.1159/000375451
Quality of Life in Acromegaly
S. Webb (2015)
10.1016/J.ARR.2005.02.001
Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging
W. Sonntag (2005)
10.1016/0022-3956(82)90033-4
Development and validation of a geriatric depression screening scale: a preliminary report.
J. Yesavage (1982)
10.1152/AJPENDO.00236.2007
Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis.
Miriam García-San Frutos (2007)
10.1016/j.maturitas.2014.05.010
Depression and the older medical patient--when and how to intervene.
P. Mitchell (2014)
10.1016/j.ghir.2010.02.003
Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients.
M. J. E. Wassenaar (2010)
Balance in elderly patients: the "get-up and go" test.
S Mathias (1986)
10.1530/EJE-08-0243
The influence of age on the GH-IGF1 axis in patients with acromegaly.
Keiji Tanimoto (2008)
FUNCTIONAL EVALUATION: THE BARTHEL INDEX.
Mahoney Fi (1965)
10.1016/0022-3956(75)90026-6
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.
M. Folstein (1975)
10.1371/journal.pone.0060041
Neurocognitive Function in Acromegaly after Surgical Resection of GH-Secreting Adenoma versus Naïve Acromegaly
J. F. Martín-Rodríguez (2013)
10.1152/JAPPLPHYSIOL.00246.2003
Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia.
F. Lauretani (2003)
10.1093/GERONT/9.3_PART_1.179
Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living
M. P. Lawton (1969)
10.7326/0003-4819-124-8-199604150-00002
Growth Hormone Replacement in Healthy Older Men Improves Body Composition but Not Functional Ability
M. Papadakis (1996)
10.1017/S1041610200006293
Reliability, validity, and factor structure of the geriatric depression scale in Turkish elderly: are there different factor structures for different cultures?
T. Ertan (2000)
10.1111/j.1365-2362.2012.02721.x
Effects of previous growth hormone excess and current medical treatment for acromegaly on cognition
P. Brummelman (2012)
10.1016/j.mad.2008.08.001
Modulation of GH/IGF-1 axis: Potential strategies to counteract sarcopenia in older adults
S. Giovannini (2008)
10.1007/s11102-011-0326-z
Cognitive function in acromegaly: description and brain volumetric correlates
C. Sievers (2011)
10.1159/000062967
The Mini Nutritional Assessment (MNA) for grading the nutritional state of elderly patients: presentation of the MNA, history and validation.
Y. Guigoz (1999)
10.1210/jc.2009-2670
A consensus on criteria for cure of acromegaly.
A. Giustina (2010)
Get up and go
G. Lawton (2006)
10.1155/2012/127362
Sarcopenia and Age-Related Endocrine Function
K. Sakuma (2012)
10.1007/s12020-014-0166-5
Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases?
P. Anagnostis (2014)
10.1093/ageing/afq034
Sarcopenia: European consensus on definition and diagnosis
A. Cruz-Jentoft (2010)
10.1210/jc.2010-0394
Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly.
J. Leon-Carrion (2010)
10.3389/fendo.2017.00040
Predictors of Quality of Life in Acromegaly: No Consensus on Biochemical Parameters
V. Geraedts (2017)
10.1007/BF02778061
Elements in the pathophysiology of diminished growth hormone (GH) secretion in aging humans
J. Veldhuis (2007)
10.1007/s10067-014-2543-0
Ultrasonographic measurement of femoral cartilage thickness in acromegalic patients
M. Karkucak (2014)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar